Optical imaging of apoptosis as a biomarker of tumor response to chemotherapy

Neoplasia

Volumn 5, Issue 3, 2003, Pages 187-192

  Schellenberger, Eyk A ^b   Bogdanov Jr , Alexei ^b   Petrovsky, Alexander ^b   Ntziachristos, Vasilis ^b   Weissleder, Ralph ^b   Josephson, Lee ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NONE

Author keywords

Annexin V(optical imaging; Apoptosis; Chemotherapy; Tumor

Indexed keywords

ANTINEOPLASTIC AGENT; BIOLOGICAL MARKER; CASPASE; CONTRAST MEDIUM; FLUORESCEIN ISOTHIOCYANATE; FLUORESCENT DYE; LIPOCORTIN 5;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CHEMOSENSITIVITY; CONSERVATIVE TREATMENT; CONTROLLED STUDY; FEMALE; FLUORESCENCE; IMAGING; MOUSE; NICK END LABELING; NONHUMAN; OPTICAL INSTRUMENTATION; PRIORITY JOURNAL; XENOGRAFT;

EID: 0013162104     PISSN: 15228002     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1476-5586(03)80050-7     Document Type: Article

References (31)

1. Blankenberg FG, Katsikis PD, Tait JF, Davis RE, Naumovski L, Ohtsuki S, Kopiwoda S, Abrams MJ, Darkes M, Robbins RC, et al. (1998). In vivo detection and imaging of phosphatidylserine expression during programmed cell death. Proc Natl Acad Sci USA 95, 6349-54.
2. Blankenberg FG, Naumovski L, Tait JF, Post AM, and Strauss HW (2001). Imaging cyclophosphamide-induced intramedullary apoptosis in rats using 99mTc-radiolabeled annexin V. J Nucl Med 42, 309-16.
3. Boehm T, Folkman J, Browder T, and O'Reilly MS (1997). Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature 390, 404-7.
4. Dive C, Gregory CD, Phipps DJ, Evans DL, Milner AE, and Wyllie AH 1992). Analysis and discrimination of necrosis and apoptosis (programmed cell death) by multiparameter flow cytometry. Biochim Biophys Acta 1133, 275-85.
5. Ernst JD, Yang L, Rosales JL, and Broaddus VC (1998). Preparation and characterization of an endogenously fluorescent annexin for detection of apoptotic cells. Anal Biochem 260, 18-23.
6. Fadok VA, Bratton DL, Frasch SC, Warner ML, and Henson PM (1998). The robe of phosphatidylserine in recognition of apoptotic cells by phagocytes. Cell Death Differ 5, 551-62.
7. Fisher DE (2001). Pathways of apoptosis and the modulation of cell death in cancer. Hematol/Oncol Clin North Am 15, 931-56.
8. Green AM, and Steinmetz, ND (2002). Monitoring apoptosis in real time. Cancer J 8, 82-92.
9. Hammill AK, Uhr JW, and Scheuermann RH (1999). Annexin V staining due to loss of membrane asymmetry, can be reversible and precede commitment to apoptotic death. Exp Cell Res 251, 16-21.
10. Henson PM, Bratton DL, and Fadok VA (2001). Apoptotic cell removal. Curr Biol 11, R795-805.
11. Kohler G, Hering U, Zschornig O, and Arnold K (1997). Annexin V interaction with phosphatidylserine-containing vesicles at low and neutral pH. Biochemistry 36, 8189-94.
12. Lowe SW (1995). Cancer therapy and p53. Curr Opin Oncol 7, 547-53.
13. Mahmood U, Tung CH, Bogdanov Jr A, and Weissleder R (1999). Near-infrared optical imaging of protease activity for tumor detection. Radiology 213, 866-70.
14. Makin G, and Dive C (2001). Apoptosis and cancer chemotherapy. Trends Cell Biol 11, S22-6.
15. Martin SJ, Reutelingsperger CP, McGahon AJ, Rader JA, van Schie RC, LaFace DM, and Green DR (1995). Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J Exp Med 182, 1545-56.
16. Mesner Jr PW, Budihardjo II, and Kaufmann SH (1997). Chemotherapy-induced apoptosis. Adv Pharmacol 41, 461-99.
17. Messmer UK, and Pfeilschifter, J (2000). New insights into the mechanism for clearance of apoptotic cells. Bioessays 22, 878-81.
18. Ntziachristos V, Bremer C, Graves EE, and Weissleder R (2002). In vivo tomographic imaging of near-infrared fluorescent probes. Mol Imaging 1, 82-8.
19. Ntziachristos V, Hielscher AH, Yodh AG, and Chance B (2001). Diffuse optical tomography of highly heterogeneous media. IEEE Trans Med Imaging 20, 470-8.
20. Ntziachristos V, Ripoli J, and Weissleder R (2002). Would near-infrared fluorescence signals propagate through large human organs for clinical studies? Opt Lett 27, 333-5.
21. Pigault C, Follenius-Wund A, Schmutz M, Freyssinet JM, and Brisson A (1994). Formation of two-dimensional arrays of annexin V on phosphatidylserine-containing liposomes. J Mol Biol 236, 199-208.
22. Platt N, da Silva RP, and Gordon S (1998). Recognizing death: the phagocytosis of apoptotic cells. Trends Cell Biol 8, 365-72.
23. Poot M, Gibson LL, and Singer VL (1997). Detection of apoptosis in live cells by Mito Tracker red CMXRos and SYTO dye flow cytometry. Cytometry 27, 358-64.
24. Schmitt CA, and Lowe SW (2002). Apoptosis and chemoresistance in transgenic cancer models. J Mol Med 80, 137-46.
25. Span LF, Pennings AH, Vierwinden G, Boezeman JB, Raymakers RA, and de Witte T (2002). The dynamic process of apoptosis analyzed by flow cytometry using Annexin-V/propidium iodide and a modified in situ end labeling technique. Cytometry 47, 24-31.
26. van Engeland M, Nieland LJ, Ramaekers FC, Schutte B, and Reutelingsperger CP (1998). Annexin V affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry 31, 1-9.
27. Waring P, Lambert D, Sjaarda A, Hurne A, and Beaver J (1999). Increased cell surface exposure of phosphatidylserine on propidium iodide negative thymocytes undergoing death by necrosis. Cell Death Differ 6, 624-37.
28. Weissleder R, Tung CH, Mahmood U, and Bogdanov Jr A (1999). In vivo imaging of tumors with protease-activated near-infrared fluorescent probes. Nat Biotechnol 17, 375-8.
29. Ohtsuki K, Akashi K, Aoka Y, Blankenburg FG, Kpiwods S, Tait JF, and Strauss HW (1999). Techetium-99m HYNIC-annexin V: a potential radiopharmaceutical for the in vivo detection of apoptosis. Eur J Nucl Med 26, 1251-8.
30. Bhunchet E, Hatakawa H, Sakai Y, and Shibata T (2002). Fluorescein electronic endoscopy: a novel method for detection of early stage gastric cancer not evident to routine endoscopy. Gastrointest Endosc 55, 562-71.
31. Kobayashi M, Tajiri H, Seike E, Shitaya M, Tounou S, Mine M, and Oba K (2001). Detection of early gastric cancer by a real-time autofluorescence imaging system. Cancer Lett 165, 155-9.